+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry

  • ID: 5449106
  • Report
  • September 2021
  • Region: Global
  • 112 Pages
  • BCC Research
UP TO OFF until May 31st 2022

FEATURED COMPANIES

  • Biologics Modular, Llc
  • CYTIVA
  • ESC
  • Exyte GmbH
  • G-con Manufacturing Inc.
  • IPM Technologies

Report Scope

This report provides a detailed description of flexible manufacturing systems in the pharmaceutical industry and the latest technologies in the market.




The report includes market estimates for different types of flexible manufacturing systems and also includes recent technological developments and assessments of product performance in the market.


  • The global market for flexible manufacturing systems in the pharmaceutical industry should grow from $1.8 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026. 
  • Modular manufacturing market for flexible manufacturing systems in the pharmaceutical industry should grow from $858.4 million in 2021 to $1.1 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
  • Data-driven manufacturing market for flexible manufacturing systems in the pharmaceutical industry should grow from $501.0 million in 2021 to $665.6 million by 2026 with a compound annual growth rate (CAGR) of 5.8% for the period of 2021-2026.

Based on the approach type, the flexible manufacturing systems in pharmaceutical industry is segmented into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.


Based on application, the market is segmented into manufacturing, aseptic filling and others (research and development, clinical research and academic research).


Based on industry, the market is segmented into pharmaceutical and biotechnology.


The report discusses the qualitative and quantitative factors influencing the market growth. The market drivers, restraints and opportunities are discussed in the report.


This report discusses some of the major drivers and restraints as well as the competition and key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions.


The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report additionally provides insights on the market share and upcoming regional demand.


Some of the major market players discussed in the report are Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc. For market estimates, data have been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.


Report Includes:

  • 22 data tables and 20 additional tables
  • An overview of the global market for flexible manufacturing systems in the pharmaceutical industry
  • Estimation of the market size and analyses of the global market trends, with data from 2019, 2020, estimates for 2021 with projection of CAGR through 2026
  • Market share analysis of flexible manufacturing systems based on approaches, industry type, application, and geography, and identification of new opportunities, challenges, and technological changes within the industry
  • Detailed description of flexible manufacturing system, its working, objectives, benefits, and limitations
  • Detailed analysis of the regulatory framework and policies, reimbursement scenarios and key product and technology developments
  • Identification of economic and demographic factors affecting the market growth and market insights about the future of the industry
  • Information on quicker approval processes of regulatory authorities for the new drugs, and initiatives by international organizations to improve flexible manufacturing systems
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of major players in the market, including Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc.
Frequently Asked Questions about the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry

What is the estimated value of the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry?

The Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry was estimated to be valued at $1.8 Billion in 2021.

What is the growth rate of the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry?

The growth rate of the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry is 5.4%, with an estimated value of $2.3 Billion by 2026.

What is the forecasted size of the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry?

The Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry is estimated to be worth $2.3 Billion by 2026.

Who are the key companies in the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry?

Key companies in the Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry include Biologics Modular, Llc, CYTIVA, ESC, Exyte GmbH, G, con Manufacturing Inc., Germfree Laboratories Inc., IPM Technologies and Keyplants Ab.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biologics Modular, Llc
  • CYTIVA
  • ESC
  • Exyte GmbH
  • G-con Manufacturing Inc.
  • IPM Technologies

Chapter 1 Introduction
  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports


Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Flexible Manufacturing Systems-Overview
  • How Does a Flexible Manufacturing System Work?
  • Objectives of FMS
  • Benefits of FMS
  • Limitations of FMS
  • Flexibility in Pharmaceutical Manufacturing
  • Flexibility-The Future of Pharma Manufacturing
  • The New Pharma Reality
  • Single-use Systems for Biopharmaceuticals
  • Continuous Manufacturing
  • Modular Manufacturing
  • Industry 4.0 in Pharma Manufacturing
  • Time to Act
  • Artificial Intelligence
  • Increasing Adoption of Industrial Internet of Things (IIoT)
  • Conclusions
  • Regulatory Aspects
  • Current Goods Manufacturing Practices (CGMPs) Overview
  • Importance of CGMPs
  • Existing Regulatory Guidelines on CM


Chapter 4 Impact of COVID-19 Pandemic
  • Impact of COVID-19
  • Need for Modular Manufacturing Approach
  • Speed to Market
  • Flexible Capacity
  • The Vaccine Facility of the Future
  • U.S. Biocontainment Manufacturer Provides Mobile Laboratory Facility for Work on COVID-19 Vaccine
  • 130,000 Square-foot Drug Manufacturing Facility in Seattle Area Developed COVID-19 Therapeutics
  • New Collaboration Between Exyte and Univercells Technologies for Quick Deployment of Vaccine Production Plants to Combat the COVID-19 Pandemic


Chapter 5 Market Dynamics
  • Market Drivers
  • Increased Emphasis on Lowering Manufacturing Costs and Unpredictable Demand for Different Products
  • Regulatory Authorities Support New Manufacturing Trends by Offering Quicker Approval Processes for New Drugs
  • The Need for Process Optimization and Improvements in the Supply Chain Is Driving Investment in Automation Technologies Across the Pharmaceutical Industry
  • Current Rise in Demand for Biopharmaceuticals Due to COVID-19 Has Driven the Need for Strategic Changes in Bioprocessing
  • Market Restraints
  • Slow Rate of Adoption as the Industry Faces a Large Existing Capital Footprints, and Inconsistency in the Global Regulatory Framework
  • Uncertain Regulatory Policies
  • Market Opportunities
  • Initiatives by International Organizations to Improve Flexible Manufacturing Systems
  • Rising Opportunities with Industry 4.0 and Pharma 4.0
  • Competitive Landscape
  • Cytiva
  • Jacobs
  • Exyte GmbH


Chapter 6 Market Breakdown by Approach
  • Global Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach
  • Modular Manufacturing
  • Market Size and Forecast
  • Data-driven Manufacturing
  • Key Benefits of Data-driven Manufacturing in the Pharmaceutical Industry
  • Market Size and Forecast
  • Single-use Manufacturing
  • Market Size and Forecast
  • Continuous Manufacturing
  • Market Size and Forecast


Chapter 7 Market Breakdown by Application
  • Global Flexible Manufacturing Systems in the Pharmaceutical Industry, by Application
  • Manufacturing
  • Market Size and Forecast
  • Aseptic Filling
  • Market Size and Forecast
  • Others
  • Market Size and Forecast


Chapter 8 Market Breakdown by Industry
  • Global Flexible Manufacturing Systems in the Pharmaceutical Industry Market, by End-Use Industry
  • Pharmaceutical
  • Market Size and Forecast
  • Biotechnology
  • Market Size and Forecast


Chapter 9 Market Breakdown by Region
  • Global Flexible Manufacturing Systems in Pharmaceutical Industry Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • Italy
  • Switzerland
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific
  • India
  • China
  • Australia
  • Japan
  • Rest of Asia-Pacific
  • Rest of the World
  • Market Size and Forecast


Chapter 10 Company Profiles
  • Biologics Modular, Llc
  • Cytiva
  • ESC
  • Exyte Gmbh
  • G-Con Manufacturing Inc.
  • Germfree Laboratories Inc.
  • Ipm Technologies
  • Jacobs Engineering Group Inc.
  • Keyplants Ab
  • Moduleco Ltd. (Moduleco Pharma)
  • Modwave Llc
  • Univercells Technologies
  • Zeton Inc.


Chapter 11 Appendix: List of Abbreviations
List of Tables
Summary Table: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 1: List of Companies and Currently Approved Drug Products Manufactured with Continuous Manufacturing
Table 2: Existing Regulatory Guidelines on Continuous Manufacturing
Table 3: Global Flexible Manufacturing Systems in Pharmaceutical Industry Market Vendors, by Ranking, 2020
Table 4: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 5: Global Market for Modular Manufacturing System in the Pharmaceutical Industry, by Region, Through 2026
Table 6: Global Market for Data-driven Manufacturing System in the Pharmaceutical Industry, by Region, Through 2026
Table 7: Global Market for Single-use Flexible Manufacturing System in the Pharmaceutical Industry, by Region, Through 2026
Table 8: Global Market for Continuous Manufacturing System in the Pharmaceutical Industry, by Region, Through 2026
Table 9: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Application, Through 2026
Table 10: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry Manufacturing Applications, by Region, Through 2026
Table 11: Global Market for Aseptic Filling Applications for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, Through 2026
Table 12: Global Market for Flexible Manufacturing Systems in Other Pharmaceutical Industry Applications, by Region, Through 2026
Table 13: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by End-Use Industry, Through 2026
Table 14: Global Market for Pharmaceutical End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, Through 2026
Table 15: Global Market for Biotechnology End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, Through 2026
Table 16: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, Through 2026
Table 17: North American Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 18: North American Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, Through 2026
Table 19: European Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 20: European Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, Through 2026
Table 21: Asia-Pacific Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 22: Asia-Pacific Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, Through 2026
Table 23: Rest of the World Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, Through 2026
Table 24: Biologics Modular, LLC: Solutions/Services Offered
Table 25: Biologics Modular, LLC: Recent Developments, 2019 and 2021
Table 26: Cytiva: Solutions/Services Offered
Table 27: Cytiva: Recent Developments, 2021
Table 28: Exyte GmbH: Solutions/Services Offered
Table 29: Exyte GmbH: Recent Developments, 2020 and 2021
Table 30: G-CON Manufacturing Inc.: Solutions/Services Offered
Table 31: G-CON Manufacturing Inc.: Recent Developments
Table 32: Germfree Laboratory Inc.: Solutions/Services Offered
Table 33: Germfree Laboratory Inc.: Recent Developments, 2019 and 2020
Table 34: IPM Technologies: Solutions/Services Offered
Table 35: Jacobs Engineering Group Inc.: Solutions/Services Offered
Table 36: Jacobs Engineering Group Inc.: Recent Developments, 2020
Table 37: KeyPlants AB: Solutions/Services Offered
Table 38: KeyPlants AB: Recent Developments, 2020 and 2021
Table 39: ModuleCo Ltd.: Solutions/Services Offered
Table 40: Modwave LLC: Solutions/Services Offered
Table 41: Abbreviation Used in this Report
List of Figures
Summary Figure: Global Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, 2020
Figure 1: Global Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, 2020
Figure 2: Global Market for Modular Manufacturing System in the Pharmaceutical Industry, 2019-2026
Figure 3: Global Market for Modular Manufacturing System in the Pharmaceutical Industry, by Region, 2019-2026
Figure 4: Global Market for Data-driven Manufacturing System in the Pharmaceutical Industry, 2019-2026
Figure 5: Global Market for Data-driven Manufacturing System in the Pharmaceutical Industry, by Region, 2019-2026
Figure 6: Global Market for Single-use Manufacturing System in the Pharmaceutical Industry, 2019-2026
Figure 7: Global Market for Single-use Flexible Manufacturing System in the Pharmaceutical Industry, by Region, 2019-2026
Figure 8: Global Market for Continuous Manufacturing System in the Pharmaceutical Industry, 2019-2026
Figure 9: Global Market for Continuous Manufacturing System in the Pharmaceutical Industry, by Region, 2019-2026
Figure 10: Global Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Application, 2020
Figure 11: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry Manufacturing Applications, 2019-2026
Figure 12: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry Manufacturing Applications, by Region, 2019-2026
Figure 13: Global Market for Aseptic Filling Applications for Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 14: Global Market for Aseptic Filling in Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, 2019-2026
Figure 15: Global Market for Flexible Manufacturing Systems in Other Pharmaceutical Industry Applications, 2019-2026
Figure 16: Global Market for Flexible Manufacturing Systems in Other Pharmaceutical Industry Applications, by Region, 2019-2026
Figure 17: Global Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by End-Use Industry, 2020
Figure 18: Global Market for Pharmaceutical End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 19: Global Market for Pharmaceutical End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, 2019-2026
Figure 20: Global Market for Biotechnology End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 21: Global Market for Biotechnology End Use in Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, 2019-2026
Figure 22: Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, 2019-2026
Figure 23: Global Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Region, 2020
Figure 24: North American Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, 2020
Figure 25: North American Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, 2020
Figure 26: U.S. Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 27: Canadian Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 28: European Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, 2020
Figure 29: European Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, 2020
Figure 30: German Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 31: Italian Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 32: Swiss Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 33: U.K. Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 34: French Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 35: Rest of European Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 36: Asia-Pacific Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Approach, 2020
Figure 37: Asia-Pacific Market Share for Flexible Manufacturing Systems in the Pharmaceutical Industry, by Country, 2020
Figure 38: Indian Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 39: Chinese Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 40: Australian Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 41: Australian Market for Flexible Manufacturing Systems in the Pharmaceutical Industry, 2019-2026
Figure 42: Rest of Asia-Pacific Market for Flexible Manufacturing Systems in the Pharmaceutical Industry , 2019-2026
Figure 43: Cytiva: Revenue Share, by Business Segment, 2020
Figure 44: Exyte GmbH: Net Revenue, 2018-2020
Figure 45: Exyte GmbH: Revenue Share, by Business Segment, 2020
Figure 46: Exyte GmbH: Revenue Share, by Region, 2020
Figure 47: Jacobs Engineering Group Inc.: Net Revenue, 2016-2020
Figure 48: Jacobs Engineering Group Inc.: Revenue Share, by Business Segment, 2020
Figure 49: Jacobs Engineering Group Inc.: Revenue Share, by Region/Country, 2020
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Biologics Modular, Llc
  • CYTIVA
  • ESC
  • Exyte GmbH
  • G-con Manufacturing Inc.
  • IPM Technologies

Increased emphasis on lowering manufacturing costs and unpredictable demand for different products, demands more flexible and agile facilities is one of the key factors driving the market. The need for process optimization and improvements in the supply chain are driving investment in automation technologies across the pharmaceutical industry, and the current rise in demand for biopharmaceuticals due to COVID-19 has driven the need for strategic changes in bioprocessing.


Reasons for Doing This Study:

The global biopharmaceutical market is changing consistently. Earlier, the main emphasis was on bestseller drugs manufactured in large amounts. Now, the focus has changed towards a greater number of products manufactured in smaller batches. With revenues under pressure, biopharmaceutical companies are confronting growing demands to develop new drugs at a lesser cost in an ever-declining time frame.


Innovative tools and technologies that streamline operations and decrease process time can create opportunities to improve annual batch throughput. Advanced approaches that challenge conventional upstream and downstream process approaches help increase facility utilization and flexibility.


Thus, unpredictable demand coupled with volatile market behavior and a growing focus on reducing manufacturing costs for different products drives the need for more flexible and agile facilities in the pharmaceutical industry.


Different approaches of flexible manufacturing systems in the pharmaceutical industry are discussed in the report such as modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.


The study also highlights the potential growth of the market. The research will provide a detailed overview of the market players, market shares, partnerships, mergers and acquisitions, and financials.


Note: Product cover images may vary from those shown
  • Biologics Modular, Llc
  • CYTIVA
  • ESC
  • Exyte GmbH
  • G-con Manufacturing Inc.
  • Germfree Laboratories Inc.
  • IPM Technologies
  • Jacobs Engineering Group Inc.
  • Keyplants Ab
  • Moduleco Ltd. (moduleco Pharma)
  • Modwave Llc
  • Univercells Technologies
  • Zeton Inc.
Note: Product cover images may vary from those shown